Publications

2013
Rist PM, Chalmers, AC J, Arima H, et al. Baseline cognitive function, recurrent stroke, and risk of dementia in stroke patients. Stroke. 2013;44:1790-95.
Hata J, Arima H, Zoungas S, et al. Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial. PLOS ONE. 2013;8.
Perkovic V, Heerspink HL, Chalmers, AC J, et al. Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney International. 2013;83:517-23.
2012
McAlister FA, Marzona I, Dagenais GR, et al. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials. European Heart Journal. 2012;33:505-14.
Zoungas S, Chalmers, AC J, Ninomiya T, et al. Association of HbA(1c) levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia. 2012;55:636-643.
Arima H, Anderson CS, Omae T, et al. Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial. Stroke. 2012;43:1675-7.
LV J, Neal BC, Ehteshami P, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis. PLoS Medicine. 2012;9:e1001293.
Hata J, Arima H, Rothwell PM, et al. Effects of visit-to-visit blood pressure variability on macrovascular and microvascular events in patients with type 2 diabetes: the ADVANCE trial. In: 21st European Stroke Conference. 21st European Stroke Conference. Lisbon, Portugal; 2012.
MacMahon S. “Frugal” healthcare innovation – a global research priority. In: The Academy of Medical Sciences. New Fellows admission day. The Academy of Medical Sciences. New Fellows admission day. London, United Kingdom; 2012.
MacMahon S. Frugal innovation - The future of cardiovascular medicine. In: Lewis A. Conner Memorial Lecture, Scientific Sessions, American Heart Association. Lewis A. Conner Memorial Lecture, Scientific Sessions, American Heart Association. Los Angeles, USA; 2012.
Bennett DA, Eliasz TK, Forbes A, et al. Study protocol: systematic review of the burden of heart failure in low- and middle-income countries. Cochrane Database of Systematic Reviews. 2012;1:59.
Joshi R, Chow C, Raju PK, et al. The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial. Journal of the American College of Cardiology. 2012;59:1188-96.
Peiris D, Usherwood T, Panaretto K, et al. The Treatment of cardiovascular Risk in Primary care using Electronic Decision supOrt (TORPEDO) study-intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention i. BMJ Open. 2012;2.
Rahimi K, Patel A, MacMahon S. Two decades of research on innovative models of care delivery for patients with heart failure: the end or just the beginning?. Archives of Iranian Medicine. 2012;15:439-45.
2011
Brugts JJ, Isaacs A, de Maat MP, et al. A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals. Journal of Hypertension. 2011;29:509-19.
Jennings G, MacMahon S, Donnan G. Cuts to the NHMRC budget will undermine the health of all Australians - today and in the future. Medical Journal of Australia. 2011;194:436-7.
Arima H, Anderson CS, Omae T, et al. Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial. Stroke. 2011;42:2339-2341.
MacMahon S. Experiences of Chronic Disease Prevention and Control during Social Transition. In: China International Center for Chronic Disease Prevention, Heping Hospital of Changzhi Medical College Health Policy Roundtable 2011 - Theme: Challenges and Strategies for Chronic Disease Prevention and Control in Transitional Society. China International Center for Chronic Disease Prevention, Heping Hospital of Changzhi Medical College Health Policy Roundtable 2011 - Theme: Challenges and Strategies for Chronic Disease Prevention and Control in Transitional Society. Shanxi, China; 2011.
MacMahon S. Global Healthcare: Innovative Affordable Strategies for Health. In: Virgin Unite – Necker Meets Oxford. Virgin Unite – Necker Meets Oxford. Necker Island, British Virgin Islands; 2011.
Gansevoort RT, Matsushita K, van der Velde M, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney International. 2011;80:93-104.
van der Velde M, Matsushita K, Coresh J, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney International. 2011;79:1341-1352.
MacMahon S. National Heart Foundation Visiting Lecturer: The prevention of heart disease – So much achieved for so few. In: Cardiac Society of Australia and New Zealand NZ Annual Scientific Meeting. Cardiac Society of Australia and New Zealand NZ Annual Scientific Meeting. Hastings, New Zealand; 2011.
Arima H, Anderson CS, Omae T, et al. Perindopril-based blood pressure lowering reduces major vascular and bleeding events in patients with cerebrovascular disease who use antithrombotic therapy: the PROGRESS trial. Stroke Society of Australasia Annual Scientific Meeting . 2011:20.
MacMahon S. Practical lessons from hypertension programmes on the Indian Sub Continent and China. In: Medical Research Council-British Hypertension Society Workshop - Global Alliance for Chronic Disease Call for Implementation Research in Hypertension in Low and Middle Income Countries. Medical Research Council-British Hypertension Society Workshop - Global Alliance for Chronic Disease Call for Implementation Research in Hypertension in Low and Middle Income Countries. London, United Kingdom; 2011.
MacMahon S. Reviewing the Evidence for Thresholds & Targets – Can we do without targets?. In: Blood Pressure Lowering Treatment Workshop -What pressures to measure and what targets to aim at?. Blood Pressure Lowering Treatment Workshop -What pressures to measure and what targets to aim at? Sarzana, Italy; 2011.

Pages